Sorry, I wasn't clear, but you are saying exactly what I was trying to say, I think that we are no longer being held back or shackled by the FDA with this new protocol. That's why I said Dr. Jay's approach was so good by having a trial that ends up being about how LL works which will become the basis for a multitude of trials instead of a trial for a single indication, let's say NASH or something.

I just wasn't very good at explaining it. I'm very happy about this approach, this is going to work. I forgot the exact words Dr. JL used to describe this new protocol.